HLA-G functions
| Effector cell, HLA-G function . | Receptors involved . | Reference . |
|---|---|---|
| NK cells | ||
| Inhibition of cytotoxic function | ILT2, KIR2DL4 | 32, 33 |
| Indirect inhibition of cytotoxic function through stabilization of cell-surface HLA-E | CD94/NKG2A (interacts w/HLA-E) | 86 |
| Inhibition of proliferation | ILT2 | 39 |
| Up-regulation of inhibitory receptors | — | 87 |
| Apoptosis | CD8 | 88, 89 |
| Increased proliferation and IFNγ production | KIR2DL4 | 46, 90 |
| Increased secretion of pro-angiogenic factors | Internalized KIR2DL4 | 47 |
| Inhibition of transendothelial migration | ILT2 | 91 |
| CD8+T cells | ||
| Inhibition of cytotoxic function | — | 34, 92 |
| Inhibition of proliferation | ILT2 | 37 |
| Generation of CD8low regulatory T cells | — | 55 |
| Apoptosis | CD8 | 89 |
| CD4+T cells | ||
| Inhibition of alloreactivity | ILT2, ILT457 | 35, 82 |
| Inhibition of proliferation | ILT2 | 37, 38 |
| Up-regulation of inhibitory receptors | — | 87 |
| Generation of regulatory T cells, which include CD4low T cells | — | 55, 82 |
| APC | ||
| Inhibition of DC maturation, antigen presentation, trafficking, and induction of regulatory T cells | ILT4 | 40 |
| Up-regulation of inhibitory receptors | — | 87 |
| PBMC: secretion of Th2 cytokines | CD160 | 93 |
| Endothelial cells: apoptosis | — | 94 |
| Effector cell, HLA-G function . | Receptors involved . | Reference . |
|---|---|---|
| NK cells | ||
| Inhibition of cytotoxic function | ILT2, KIR2DL4 | 32, 33 |
| Indirect inhibition of cytotoxic function through stabilization of cell-surface HLA-E | CD94/NKG2A (interacts w/HLA-E) | 86 |
| Inhibition of proliferation | ILT2 | 39 |
| Up-regulation of inhibitory receptors | — | 87 |
| Apoptosis | CD8 | 88, 89 |
| Increased proliferation and IFNγ production | KIR2DL4 | 46, 90 |
| Increased secretion of pro-angiogenic factors | Internalized KIR2DL4 | 47 |
| Inhibition of transendothelial migration | ILT2 | 91 |
| CD8+T cells | ||
| Inhibition of cytotoxic function | — | 34, 92 |
| Inhibition of proliferation | ILT2 | 37 |
| Generation of CD8low regulatory T cells | — | 55 |
| Apoptosis | CD8 | 89 |
| CD4+T cells | ||
| Inhibition of alloreactivity | ILT2, ILT457 | 35, 82 |
| Inhibition of proliferation | ILT2 | 37, 38 |
| Up-regulation of inhibitory receptors | — | 87 |
| Generation of regulatory T cells, which include CD4low T cells | — | 55, 82 |
| APC | ||
| Inhibition of DC maturation, antigen presentation, trafficking, and induction of regulatory T cells | ILT4 | 40 |
| Up-regulation of inhibitory receptors | — | 87 |
| PBMC: secretion of Th2 cytokines | CD160 | 93 |
| Endothelial cells: apoptosis | — | 94 |
— indicates not available.